In-house polymerase chain reaction for affordable and sustainable Chlamydia trachomatis detection in Trinidad and Tobago

Revista Panamericana de Salud Publica/Pan American Journal of Public Health

Volumn 22, Issue 5, 2007, Pages 317-322

  Rampersad, Joanne ^a,b   Wang, Xiaohui ^b   Gayadeen, Helen ^a   Ramsewak, Samuel ^a   Ammons, David ^a,b  

^a UNIVERSITY OF THE WEST INDIES   (Trinidad and Tobago)

^b UNIVERSITY OF TEXAS PAN AMERICAN   (United States)

Author keywords

Chlamydia trachomatis; Polymerase chain reaction; Trinidad and Tobago

Indexed keywords

BACTERIAL DISEASE; DETECTION METHOD; HEALTH CARE; INFECTIOUS DISEASE; POLYMERASE CHAIN REACTION; PREGNANCY; PUBLIC HEALTH; TESTING METHOD; URINE;

ATLANTIC ISLANDS; ATLANTIC OCEAN; CARIBBEAN ISLANDS; LESSER ANTILLES; TRINIDAD AND TOBAGO; TRINIDAD [TRINIDAD AND TOBAGO];

CHLAMYDIA TRACHOMATIS; NEISSERIA GONORRHOEAE;

EID: 38849111128     PISSN: 10204989     EISSN: 16805348     Source Type: Journal    
DOI: 10.1590/S1020-49892007001000004     Document Type: Article

References (20)

1. Hillis SD, Owens LM, Marchbanks PA, Amsterdam LF, MacKenzie WR. Recurrent chlamydial infections increase the risks of hospitalization for ectopic pregnancy and pelvic inflammatory disease. Am J Obstet Gynecol. 1997;176:103-7.
2. Westrom L, Joesoef R, Reynolds G, Hadgu, A, Thompson SE. Pelvic inflammatory disease and fertility, a cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopy results. Sex Transm Dis. 1992;19:185-92.
3. Numazaki K, Wainberg MA, McDonald J. Chlamydia trachomatis infections in infants. CMAJ 1989;140: 615-22.
4. Numazaki K, Asanuma H, Niida Y. Chlamydia trachomatis infection in early neonatal period. BMC Infect Dis. 2003;3:2.
5. Sherrard J, Rings M, Hall C. Where has all the chlamydia come from? The clinical impact of the introduction of an improved Chlamydia test. Int J STD AIDS 2005;16:163-5.
6. Hu D, Hook EW 3rd, Goldie SJ. Screening for Chlamydia trachomatis in women 15 to 29 years of age: a cost-effectiveness analysis. Ann Intern Med. 2004;141:501-13.
7. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2002; MMWR. 251(No. RR-6).2-34.
8. Currie MJ, McNiven M, Yee T, Schiemer U, Bowden FJ. Pooling of Clinical Specimens Prior to Testing for Chlamydia trachomatis. J Clin Microbiol. 2004;42:4866-7.
9. Eley A, Hemeg H A, Geary I, Ramsewak S, Herring A, Caul EO. Prevalence of Chlamydia trachomatis IgG antibodies in antenatal patients from Trinidad. Sex. Transm. Inf. 2001;77:30-302.
10. Barlow REL, Cooke ID, Odukoya O, et al. The prevalence of Chlamydia trachomatis in fresh tissue specimens from patients with ectopic pregnancy or tubal factor infertility as determined by PCR and insitu hybridization. J. Med. Microbiol. 2001;50:902-8.
11. Swanston WH, Prabhakar P, Barrow L, Mahabir BS, Furlonge C. Single dose (direct observed) azithromycin therapy for Neisseria gonorrhoeae and Chlamydia trachomatis in STD clinic attenders with genital discharge in Trinidad and Tobago. West Indian Med J. 2001;50:198-202.
12. Jurstrand M, Falk L, Fredlund H, et al. Characterization of Chlamydia trachomatis omp1 genotypes among sexually transmitted disease patients in Sweden. J Clin Microbiol. 2001;39: 3915-9.
13. Ho BS, Feng WG, Wong BK, Egglestone SI. Polymerase chain reaction for the detection of Neisseria gonorrhoeae in clinical samples. J Clin Pathol. 1992;45:439-42.
14. Mahony JB, Luinstra KE, Sellors JW, Jang D, Chernesky MA. Confirmatory polymerase chain reaction testing for Chlamydia trachomatis in first-void urine from asymptomatic and symptomatic men. J Clin Microbiol. 1992;30:2241-5.
15. R Development Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing: Vienna, Austria. Available from: www.R-project.org. Accessed on: 12 December 2006.
16. Leslie DE, Azzato F, Ryan N, Fyfe J. An assessment of the Roche Amplicor Chlamydia trachomatis/Neisseria gonorrhoeae multiplex PCR assay in routine diagnostic use on a variety of specimen types. Commun Dis Intell. 2003;27:373-9.
17. Moncada J, Schachter J, Hook EW 3rd, et al. The effect of urine testing in evaluations of the sensitivity of the Gen-Probe Aptima Combo 2 assay on endocervical swabs for Chlamydia trachomatis and Neisseria gonorrhoeae: the infected patient standard reduces sensitivity of single site evaluation. Sex Transm Dis. 2004;31:273-7.
18. Bang D, Angelso L, Schirakow B, Westh H. Comparison of the Becton Dickinson strand displacement amplification and Cobas Amplicor Roche PCR for the detection of Chlamydia trachomatis: pooling versus individual tests. Clin Microbiol Infect. 2003;9:1020-3.
19. Girdner JL, Cullen AP, Salama TG, He L, Lorincz A, Quinn TC. Evaluation of the Digene Hybrid Capture II CT-ID test for detection of Chlamydia trachomatis in Endocervical Specimens. J Clin Microbiol. 1999;37:1579-81.
20. Hoofar J, Cook N, Malorny, et al. Making internal amplification control mandatory for diagnostic PCR. J Clin Microbiol. 2003;4:5835.